Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of PPI Therapy on Weight, Gut Microbiome, and Expression of GPR41 and GPR43

NCT02457104 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT02457104
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02457104 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of PPI Therapy on Weight, Gut Microbiome, and Expression of GPR41 and GPR43
Lead sponsor
University of Colorado, Denver
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2015
Completion date
December 31, 2021
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastroesophageal reflux disease, obesity